Access to Drugs for Treatment of Noncommunicable Diseases

Access to Drugs for Treatment of Noncommunicable Diseases

‏‎facilitating lexical access for the fluent production of speech‎‏

‏‎the hypothesis is that recent and frequent exposure to lexical items leads to a more fluent production of speech in terms of rate of speech. to test the hypothesis , a one- way anova experimental design was carried out. 24 senior student of efl participated in a one-way interview test. data analyses revealed that those who were exposed frequently to the lexical items over a week prior to inte...

‏‎faciliting lexical access for the fluent production of speech‎‏

‏‎the hypothesis is that recent and frequent exposure to lexical items leads to a more fluent production of speech in terms of rate of speech. to test the hypothesis,a one-way anova experimental design was carried out. 24 sednior students of efl participated in a one-way interview test. data analyses revealed that those who were exposed frequently to the lexical items over a week prior to inter...

Overcoming Obstacles To Enable Access To Medicines For Noncommunicable Diseases In Poor Countries.

The modern access-to-medicines movement grew largely out of the civil-society reaction to the HIV/AIDS pandemic three decades ago. While the movement was successful with regard to HIV/AIDS medications, the increasingly urgent challenge to address access to medicines for noncommunicable diseases has lagged behind-and, in some cases, has been forgotten. In this article we first ask what causes th...

Noncommunicable diseases.

From the Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston (D.J.H.); the Public Health Foundation of India, New Delhi (K.S.R.); and the World Heart Federation, Geneva (K.S.R.). Address reprint requests to Dr. Hunter at the Departments of Epidemiology and Nutrition, Harvard School of Public Health, 677 Huntington Ave., Boston, MA 02115, or at [email protected]...